BVY

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

HIV-1-infection

Phase 1

Study of GS-3242 in Participants With HIV-1; Substudy-05

CompletedNCT07001319

Gilead SciencesHIV-1-infection

Start: 2025-05-29End: 2026-04-16Updated: 2026-05-11

Study of GS-1219 in Participants With HIV-1

TerminatedNCT07115368

Gilead SciencesHIV-1-infection

Start: 2025-08-11End: 2025-10-02Updated: 2025-10-21